Search Results - "Rominger, David H."
-
1
Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics
Published in Current opinion in pharmacology (01-02-2017)“…Highlights • Biased MOR ligands discovered using empirical, rational and natural product approaches. • Biased MOR ligands produce analgesia with fewer side…”
Get full text
Journal Article -
2
Evidence for allosteric interactions of antagonist binding to the smoothened receptor
Published in The Journal of pharmacology and experimental therapeutics (01-06-2009)“…The Smoothened receptor (Smo) mediates hedgehog (Hh) signaling critical for development, cell growth, and migration, as well as stem cell maintenance. Aberrant…”
Get more information
Journal Article -
3
Quantifying ligand bias at seven-transmembrane receptors
Published in Molecular pharmacology (01-09-2011)“…Seven transmembrane receptors (7TMRs), commonly referred to as G protein-coupled receptors, form a large part of the "druggable" genome. 7TMRs can signal…”
Get more information
Journal Article -
4
Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance
Published in The Journal of pharmacology and experimental therapeutics (01-12-2010)“…Biased G protein-coupled receptor ligands engage subsets of the receptor signals normally stimulated by unbiased agonists. However, it is unclear whether…”
Get more information
Journal Article -
5
Structure–Activity Relationships and Discovery of a G Protein Biased μ Opioid Receptor Ligand, [(3-Methoxythiophen-2-yl)methyl]({2-[(9R)‑9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the Treatment of Acute Severe Pain
Published in Journal of medicinal chemistry (24-10-2013)“…The concept of “ligand bias” at G protein coupled receptors has been introduced to describe ligands which preferentially stimulate one intracellular signaling…”
Get full text
Journal Article -
6
Divergent Transducer-specific Molecular Efficacies Generate Biased Agonism at a G Protein-coupled Receptor (GPCR)
Published in The Journal of biological chemistry (16-05-2014)“…The concept of “biased agonism” arises from the recognition that the ability of an agonist to induce a receptor-mediated response (i.e. “efficacy”) can differ…”
Get full text
Journal Article -
7
TRV0109101, a G Protein-Biased Agonist of the µ -Opioid Receptor, Does Not Promote Opioid-Induced Mechanical Allodynia following Chronic Administration
Published in The Journal of pharmacology and experimental therapeutics (01-08-2017)“…Prescription opioids are a mainstay in the treatment of acute moderate to severe pain. However, chronic use leads to a host of adverse consequences including…”
Get more information
Journal Article -
8
Biased ligands: pathway validation for novel GPCR therapeutics
Published in Current opinion in pharmacology (01-06-2014)“…Graphical abstract…”
Get full text
Journal Article -
9
A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine
Published in The Journal of pharmacology and experimental therapeutics (01-03-2013)“…The concept of ligand bias at G protein-coupled receptors broadens the possibilities for agonist activities and provides the opportunity to develop safer, more…”
Get more information
Journal Article -
10
Characterization of [125I]sauvagine binding to CRH2 receptors: membrane homogenate and autoradiographic studies
Published in The Journal of pharmacology and experimental therapeutics (01-07-1998)“…We describe the binding of [125I]tyr(o)sauvagine to membranes of corticotropin-releasing hormone (CRH2) receptor expressing HEK293/EBNA (293ECRH2 alpha) cells…”
Get more information
Journal Article -
11
Pharmacological characterization of a novel nonpeptide antagonist radioligand, (+/-)-N-[2-methyl-4-methoxyphenyl]-1-(1-(methoxymethyl) propyl)-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine ([3H]SN003) for corticotropin-releasing factor1 receptors
Published in The Journal of pharmacology and experimental therapeutics (01-04-2003)“…The in vitro pharmacological profile of a novel small molecule corticotropin-releasing factor 1 (CRF(1)) receptor antagonist,…”
Get more information
Journal Article -
12
Presenilin-1 and -2 Are Molecular Targets for γ-Secretase Inhibitors
Published in The Journal of biological chemistry (03-11-2000)“…Presenilins are integral membrane protein involved in the production of amyloid β-protein. Mutations of the presenilin-1 and -2 gene are associated with…”
Get full text
Journal Article -
13
Presenilin-1 and -2 Are Molecular Targets for γ-Secretase Inhibitors
Published in The Journal of biological chemistry (03-11-2000)“…Presenilins are integral membrane protein involved in the production of amyloid β-protein. Mutations of the presenilin-1 and -2 gene are associated with…”
Get full text
Journal Article